Goldman Sachs Starts BCR, CFN at Buy; ISRG, VAR at Sell; BDX Upgraded, ZMH Downgraded
Tweet Send to a Friend
Goldman Sachs is repositioning the portfolio in Medical Technology. As a results the firm initiates coverage on CR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
